Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musa

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
Genes and Immunity|December 1, 2006
IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in SudanM A Salih, M E Ibrahim, J M Blackwell, et al.
Frontiers in Cellular and Infection Microbiology|June 19, 2018
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral LeishmaniasisAnke E Kip, Monique Wasunna, Fabiana Alves, et al.
Annals of Tropical Medicine and Parasitology|March 11, 2003
The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic featuresA M Musa, E A G Khalil, M A Raheem, et al.
The American Journal of Tropical Medicine and Hygiene|February 22, 2023
LMIC Research Centers' Experiences Hosting U.S. and LMIC Trainees: Evaluation of the Fogarty Global Health Fellows and Scholars Program, 2012 to 2020Baba M Musa, Leslie Pierce, Leslie C M Johnson, et al.
Public Health Genomics|January 7, 2010
Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese populationS Farouk, M A Salih, A M Musa, et al.
Genes|June 12, 2019
Distribution of Duffy Phenotypes among <i>Plasmodium vivax</i> Infections in SudanMusab M A Albsheer, Kareen Pestana, Safaa Ahmed, et al.
Annals of Saudi Medicine|June 5, 2014
Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatmentAbubakr O A, Mohamed M M, Hatim A A, et al.
BMC Infectious Diseases|December 4, 2014
Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patientsMohamed A M Salih, Michaela Fakiola, Mohamed H Abdelraheem, et al.
International Journal of Translational Medical Research and Public Health|July 20, 2022
Building Physician-Scientist Skills in R Programming:A Short Workshop ReportMuktar H Aliyu, Mahmoud U Sani, Donna J Ingles, et al.
Plos Neglected Tropical Diseases|November 5, 2010
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding studyAhmed M Musa, Brima Younis, Ahmed Fadlalla, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
Genes and Immunity|December 1, 2006
IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in SudanM A Salih, M E Ibrahim, J M Blackwell, et al.
Frontiers in Cellular and Infection Microbiology|June 19, 2018
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral LeishmaniasisAnke E Kip, Monique Wasunna, Fabiana Alves, et al.
Annals of Tropical Medicine and Parasitology|March 11, 2003
The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic featuresA M Musa, E A G Khalil, M A Raheem, et al.
The American Journal of Tropical Medicine and Hygiene|February 22, 2023
LMIC Research Centers' Experiences Hosting U.S. and LMIC Trainees: Evaluation of the Fogarty Global Health Fellows and Scholars Program, 2012 to 2020Baba M Musa, Leslie Pierce, Leslie C M Johnson, et al.
Public Health Genomics|January 7, 2010
Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese populationS Farouk, M A Salih, A M Musa, et al.
Genes|June 12, 2019
Distribution of Duffy Phenotypes among <i>Plasmodium vivax</i> Infections in SudanMusab M A Albsheer, Kareen Pestana, Safaa Ahmed, et al.
Annals of Saudi Medicine|June 5, 2014
Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatmentAbubakr O A, Mohamed M M, Hatim A A, et al.
BMC Infectious Diseases|December 4, 2014
Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patientsMohamed A M Salih, Michaela Fakiola, Mohamed H Abdelraheem, et al.
International Journal of Translational Medical Research and Public Health|July 20, 2022
Building Physician-Scientist Skills in R Programming:A Short Workshop ReportMuktar H Aliyu, Mahmoud U Sani, Donna J Ingles, et al.
Plos Neglected Tropical Diseases|November 5, 2010
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding studyAhmed M Musa, Brima Younis, Ahmed Fadlalla, et al.
Pageof 26